Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion type Assertion NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_head.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion description "[Activation of the ERBB PI3K/Akt pathway was positively correlated with a higher stage (p=0.001), higher grade (p=0.001), histological type II disease (p=0.0003) and metastases (p=0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_provenance.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion evidence source_evidence_literature NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_provenance.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion SIO_000772 24337234 NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_provenance.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion wasDerivedFrom befree-20150227 NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_provenance.
- NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_assertion wasGeneratedBy ECO_0000203 NP624561.RA0TWbPf6B1R_ZiQBrd1IDzUdH4lPHdRGwLgZkvWTaiL4130_provenance.